---

Prosjekter med finansiering etter utlysning av programmidler i 2017:

Prosjekt	Søkerinstitusjon / prosjektleder	Tildeling (mill. kroner)
BEta-Blocker Treatment after Acute Myocardial Infarction in revascularized patients with preserved left ventricular systolic function (BETAMI trial)	Oslo universitetssykehus HF/ Dan Atar	20.00
Improved prediction of outcome by global strain and mechanical dispersion in patients with myocardial infarction, heart failure and primary prophylactic internal defibrillator.	Oslo universitetssykehus HF/ Thor Edvardsen	15.49
Establishment of Molecular profiling for Individual clinical routine Treatment decisions in Early Breast Cancer (EMIT) – clinical trials	Oslo universitetssykehus HF/ Bjørn Naume	17.57
BackToBasic	Oslo universitetssykehus HF/ John-Anker Zwart	13.84
Innovative steroid treatment to reduce asthma development in first-time rhinovirus induced wheezing – INSTAR	St. Olav’s hospital HF/ Henrik Døllner	19.32
Immunotherapy for Hematological Malignancies – A Path to Cure	St. Olav’s hospital HF/ Henrik Hjorth-Hansen	12.43
Sphenopalatine ganglion block in chronic migraine (MIBLOCK)	St. Olav’s hospital HF/ Anders Mattias Linde	18.72
Changing the specialist mental health care	Helse Bergen HF/ Gerd Kvale	19.97

---

Prosjekter med finansiering etter utlysning av programmidler i 2016:

Prosjekt	Søkerinstitusjon / prosjektleder	Tildeling (mill. kroner)
Randomized autologous hematopoietic stem cell transplantation vs. Alemtuzumab for patients with relapsing remitting Multiple Sclerosis (RAM-MS)	Helse Bergen HF / Lars Bø	19.97
A Phase 1b/2 clinical trial with Axl kinase inhibitor BGB324 in combination with Dabrafenib/Trametinib or Pembrolizumab in metastatic melanoma: Identification of predictive markers of response	Helse Bergen HF / Oddbjørn Straume	17.57
Acetylsalisylic acid as secondary prevention in colorectal cancer (ASAC Trial)	Oslo universitetssykehus HF / Bjørn Atle Bjørnbeth	13.84
The Norwegian Antibiotics for Pneumonia in Children (NAPiC) study	Oslo universitetssykehus HF / Håvard Ove Skjerven	19.32
A Norwegian multicentre trial assessing the effectiveness of tailoring infliximab treatment by therapeutic drug monitoring, the NOR-DRUM study	Diakonhjemmet Sykehus / Espen A. Haavardsholm	12.43
PRevention of cArdiac Dysfunction during Adjuvant breast cancer therapy (PRADA-2): A randomized, placebo-controlled, multicenter Trial	Akershus universitetssykehus HF / Torbjørn Omland	20.00
Tenecteplase in wake-up ischaemic stroke trial – TWIST	Universitetssykehuset Nord-Norge HF / Ellisiv B. Mathiesen	15.49